Your browser doesn't support javascript.
loading
Re-establishing the comprehension of phytomedicine and nanomedicine in inflammation-mediated cancer signaling.
Jha, Niraj Kumar; Arfin, Saniya; Jha, Saurabh Kumar; Kar, Rohan; Dey, Abhijit; Gundamaraju, Rohit; Ashraf, Ghulam Md; Gupta, Piyush Kumar; Dhanasekaran, Sugapriya; Abomughaid, Mosleh Mohammad; Das, Sabya Sachi; Singh, Sachin Kumar; Dua, Kamal; Roychoudhury, Shubhadeep; Kumar, Dhruv; Ruokolainen, Janne; Ojha, Shreesh; Kesari, Kavindra Kumar.
Affiliation
  • Jha NK; Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Greater Noida 201310, India. Electronic address: nirajkumarjha2011@gmail.com.
  • Arfin S; Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Sec 125, Noida 201303, India.
  • Jha SK; Department of Biotechnology, School of Engineering & Technology (SET), Sharda University, Greater Noida 201310, India.
  • Kar R; Indian Institute of Management Ahmedabad (IIMA), Gujarat 380015, India.
  • Dey A; Department of Life Sciences, Presidency University, College Street, Kolkata 700073, India.
  • Gundamaraju R; ER Stress and Mucosal Immunology Laboratory, School of Health Sciences, University of Tasmania, Launceston, TAS 7248, Australia.
  • Ashraf GM; Pre-Clinical Research Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia; Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Gupta PK; Department of Life Sciences, School of Basic Sciences and Research, Sharda University, Plot 32-34, Knowledge Park III, Greater Noida 201310, India.
  • Dhanasekaran S; Medical Laboratory Sciences Department, College of Applied Medical Sciences, University of Bisha, Bisha 67714, Saudi Arabia.
  • Abomughaid MM; Medical Laboratory Sciences Department, College of Applied Medical Sciences, University of Bisha, Bisha 67714, Saudi Arabia.
  • Das SS; Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, 835215 Ranchi, Jharkhand, India.
  • Singh SK; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara 144001, India.
  • Dua K; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, Sydney, NSW 2007, Australia; Australian Research Centre in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Ultimo, Sydney, NSW 2007, Australia.
  • Roychoudhury S; Department of Life Science and Bioinformatics, Assam University, Silchar, India.
  • Kumar D; Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Sec 125, Noida 201303, India.
  • Ruokolainen J; Department of Applied Physics, School of Science, Aalto University, 00076 Espoo, Finland.
  • Ojha S; Department of Pharmacology and Therapeutics, Collegeof Medicine and Health Sciences, United Arab Emirates University, Al Ain, P.O. Box 15551, United Arab Emirates.
  • Kesari KK; Department of Applied Physics, School of Science, Aalto University, 00076 Espoo, Finland. Electronic address: kavindra.kesari@aalto.fi.
Semin Cancer Biol ; 86(Pt 2): 1086-1104, 2022 11.
Article in En | MEDLINE | ID: mdl-35218902
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Phosphatidylinositol 3-Kinases / Nanomedicine Type of study: Prognostic_studies Limits: Humans Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Phosphatidylinositol 3-Kinases / Nanomedicine Type of study: Prognostic_studies Limits: Humans Language: En Year: 2022 Type: Article